CNBX Pharmaceuticals CNBX
OTC CNBX
$0.00 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

CNBX Pharmaceuticals Inc. (CNBX) Assets (2013 - 2026)

CNBX Pharmaceuticals' (CNBX) quarterly Assets came in at $12795.0 in Q2 2026, down 31.27% YoY from $18615.0 in Q2 2025, and down 14.12% on a QoQ basis from $14899.0 in Q1 2026.

CNBX Pharmaceuticals Inc. (CNBX) Assets (2013 - 2026) Analysis & Trends

CNBX Pharmaceuticals (CNBX) has 14 years of Assets data on file, last reported at $12795.0 in Q2 2026.

  • Quarterly Assets fell 31.27% year-over-year to $12795.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was $12795.0 (down 31.27% YoY) and the FY2025 annual result came in at $18437.0, down 41.25% from the prior year.
  • Assets slipped to $12795.0 in Q2 2026, from $14899.0 in the prior quarter.
  • In the past five years, Assets ranged from a high of $1.1 million in Q1 2022 to a low of $11162.0 in Q4 2025.
  • A 5-year average of $331052.2 and a median of $121972.0 in 2024 frame the typical range for Assets.
  • Annual changes were most pronounced in 2024 — Assets plunged 94.24% — and 2026, when it slumped 31.27%.
  • Tracing CNBX's Assets over 5 years: stood at $609509.0 in 2022, then tumbled by 36.44% to $387402.0 in 2023, then sank by 94.24% to $22308.0 in 2024, then plunged by 49.96% to $11162.0 in 2025, then grew by 14.63% to $12795.0 in 2026.
  • The last three Assets figures came in at $12795.0 (Q2 2026), $14899.0 (Q1 2026), and $11162.0 (Q4 2025), per Business Quant data.

Peer Comparison

Historic Data

Download Data
DateValue
May 31, 2026 12,795.00
Feb 28, 2026 14,899.00
Nov 30, 2025 11,162.00
Aug 31, 2025 18,437.00
May 31, 2025 18,615.00
Feb 28, 2025 50,660.00
Nov 30, 2024 22,308.00
Aug 31, 2024 31,383.00
May 31, 2024 80,027.00
Feb 29, 2024 163,917.00
Nov 30, 2023 387,402.00
Aug 31, 2023 499,039.00
May 31, 2023 662,019.00
Feb 28, 2023 462,052.00
Nov 30, 2022 609,509.00
Aug 31, 2022 811,166.00
May 31, 2022 965,740.00
Feb 28, 2022 1.14 Mn
Nov 30, 2021 2.12 Mn
Aug 31, 2021 3.08 Mn